Ucb SA Sustainability Reports
UCB S.A. is a global biopharmaceutical company focusing on the discovery and development of innovative medicines and solutions. Its core therapeutic areas of research and commercialization specialize in severe diseases within neurology and immunology.
Sector: Manufacturing
Country: Belgium
Exchange: Euronext Brussels
ISIN: BE0003739530
22 reports from 2006 to 2025